HLX07 alone or combined with serplulimab, cisplatin and 5‐fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study
Zhenbo Tan, Mudan Yang, Xuhui Hu, Yuan Yuan et al.
Citations
4 citations
Journal
Cancer Communications
Topics
Lymphoma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
1.70
article
HLX07 alone or combined with serplulimab, cisplatin and 5‐fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study
Zhenbo Tan, Mudan Yang, Xuhui Hu, Yuan Yuan, Ying Wang, Ning Li, Bo Liu, Yanfeng Wang, Jing Huang, Haoyu Yu, Tao Wu, Jiayan Chen, Jin Zhou, Jun Zhu, Yanrong Zhu, Zhenyang Liu, Wu Zhuang, Yun Liu, Qingyu Wang, Lin Wang
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer CommunicationsVol. 44(12)
Institutions
Hebei Medical University (CN), Academy of Medical Sciences (GB), Central South University (CN), University of Electronic Science and Technology of China (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), Zhengzhou University (CN), Fudan University Shanghai Cancer Center (CN), Shandong Tumor Hospital (CN), Shanxi Provincial Cancer Hospital (CN), National Supercomputing Center in Shenzhen (CN), Xingtai People's Hospital (CN), Hunan Cancer Hospital (CN), Sichuan Cancer Hospital (CN), National Clinical Research (US), Xuzhou Central Hospital (CN), Cancer Hospital of Chinese Academy of Medical Sciences (CN), Henan Cancer Hospital (CN), Fujian Provincial Cancer Hospital (CN), Viva Biotech (China) (CN), Shenzhen Blood Center (CN), Anyang Tumor Hospital (CN), Shandong First Medical University (CN)